Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 60
Filter
3.
Molecules ; 27(10)2022 May 13.
Article in English | MEDLINE | ID: mdl-35630619

ABSTRACT

Tyrosinase is the enzyme involved in melanization and is also responsible for the browning of fruits and vegetables. Control of its activity can be carried out using inhibitors, which is interesting in terms of quantitatively understanding the action of these regulators. In the study of the inhibition of the diphenolase activity of tyrosinase, it is intriguing to know the strength and type of inhibition. The strength is indicated by the value of the inhibition constant(s), and the type can be, in a first approximation: competitive, non-competitive, uncompetitive and mixed. In this work, it is proposed to calculate the degree of inhibition (iD), varying the concentration of inhibitor to a fixed concentration of substrate, L-dopa (D). The non-linear regression adjustment of iD with respect to the initial inhibitor concentration [I]0 allows for the calculation of the inhibitor concentration necessary to inhibit the activity by 50%, at a given substrate concentration (IC50), thus avoiding making interpolations between different values of iD. The analytical expression of the IC50, for the different types of inhibition, are related to the apparent inhibition constant (KIapp). Therefore, this parameter can be used: (a) To classify a series of inhibitors of an enzyme by their power. Determining these values at a fixed substrate concentration, the lower IC50, the more potent the inhibitor. (b) Checking an inhibitor for which the type and the inhibition constant have been determined (using the usual methods), must confirm the IC50 value according to the corresponding analytical expression. (c) The type and strength of an inhibitor can be analysed from the study of the variation in iD and IC50 with substrate concentration. The dependence of IC50 on the substrate concentration allows us to distinguish between non-competitive inhibition (iD does not depend on [D]0) and the rest. In the case of competitive inhibition, this dependence of iD on [D]0 leads to an ambiguity between competitive inhibition and type 1 mixed inhibition. This is solved by adjusting the data to the possible equations; in the case of a competitive inhibitor, the calculation of KI1app is carried out from the IC50 expression. The same occurs with uncompetitive inhibition and type 2 mixed inhibition. The representation of iD vs. n, with n=[D]0/KmD, allows us to distinguish between them. A hyperbolic iD vs. n representation that passes through the origin of coordinates is a characteristic of uncompetitive inhibition; the calculation of KI2app is immediate from the IC50 value. In the case of mixed inhibitors, the values of the apparent inhibition constant of meta-tyrosinase (Em) and oxy-tyrosinase (Eox), KI1app and the apparent inhibition constant of metatyrosinase/Dopa complexes (EmD) and oxytyrosinase/Dopa (EoxD), KI2app are obtained from the dependence of iD vs. n, and the results obtained must comply with the IC50 value.


Subject(s)
Enzyme Inhibitors , Monophenol Monooxygenase , Enzyme Inhibitors/chemistry , Levodopa
4.
Mol Genet Genomics ; 297(3): 859-871, 2022 May.
Article in English | MEDLINE | ID: mdl-35451682

ABSTRACT

The aim of this study was to assess the prevalence of germline variants in cancer-predisposing genes by either targeted (BRCA1/2) or multigene NGS panel in a high-risk Hereditary Breast and Ovarian Cancer (HBOC) cohort. Samples from 824 Caucasian probands were retrospectively collected and the impact of genetic diagnosis and genetic variants epidemiology in this cohort was evaluated. Performance of risk-reducing prophylactic measures, such as prophylactic mastectomy and/or prophylactic oophorectomy, was assessed through clinical follow-up of patients with a positive genetic result. Pathogenic variants predisposing to HBOC were identified in 11.9% (98/824) individuals at BRCA2 (47/98), BRCA1 (24/98), PALB2 (8/51), ATM (7/51), CHEK2 (6/51) MSH6, (2/51), RAD51C (2/51) and TP53 (2/386). Of them, 11 novel pathogenic variants and 12 VUS were identified, characterized, and submitted to ClinVar. Regarding clinical impact, the risk of developing basal or Her2 breast cancer was increased 15.7 times or 37.5 times for BRCA1 and MSH6 pathogenic variants respectively. On the contrary, the risk of developing basal or luminal A breast cancer was reduced to 81% or 77% for BRCA2 and BRCA1 pathogenic variants, respectively. Finally, 53.2% of individuals testing positive for class IV/V variants underwent prophylactic surgery (mastectomy, oophorectomy or both) being significantly younger at the cancer diagnosis than those undertaking prophylactic measures (p = 0.008). Of them, 8 carried a pathogenic/likely pathogenic variant in other genes different from BRCA1 and BRCA2, and the remaining (46.7%) decided to continue with clinical follow-up. No differences in pathogenicity or risk of developing cancer were found for BRCA1/2 between targeted and multigene sequencing strategies; however, NGS was able to resolve a greater proportion of high-risk patients.


Subject(s)
Breast Neoplasms , Germ-Line Mutation , Ovarian Neoplasms , Breast Neoplasms/diagnosis , Breast Neoplasms/epidemiology , Breast Neoplasms/genetics , DNA-Binding Proteins/genetics , Female , Genetic Predisposition to Disease , Germ-Line Mutation/genetics , Humans , Mastectomy , Ovarian Neoplasms/epidemiology , Ovarian Neoplasms/genetics , Retrospective Studies , Spain
5.
J Food Biochem ; : e13803, 2021 Jul 04.
Article in English | MEDLINE | ID: mdl-34219246

ABSTRACT

The oxidation of oleuropein and 3-hydroxytyrosol by oxidases laccase, tyrosinase, and peroxidase has been studied. The use of a spectrophotometric method and another spectrophotometric chronometric method has made it possible to determine the kinetic parameters Vmax and KM for each enzyme. The highest binding affinity was shown by laccase. The antioxidant capacities of these two molecules have been characterized, finding a very similar primary antioxidant capacity between them. Docking studies revealed the optimal binding position, which was the same for the two molecules and was a catalytically active position. PRACTICAL APPLICATIONS: One of the biggest environmental problems in the food industry comes from olive oil mill wastewater with a quantity of approximately 30 million tons per year worldwide. In addition, olive pomace, the solid residue obtained from the olive oil production, is rich in hydroxytyrosol and oleuropein and the action of enzymatic oxidases can give rise to products in their reactions that can lead to polymerization. This polymerization can have beneficial effects because it can increase the antioxidant capacity with potential application on new functional foods or as feed ingredients. Tyrosinase, peroxidase, and laccase are the enzymes degrading these important polyphenols. The application of a spectrophotometric method for laccase and a chronometric method, for tyrosinase and peroxidase, allowed us to obtain the kinetic information of their reactions on hydroxytyrosol and oleuropein. The kinetic information obtained could advance in the understanding of the mechanism of these important industrial enzymes.

8.
Surg Obes Relat Dis ; 17(1): 36-43, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33097450

ABSTRACT

BACKGROUND: Many options have been put forward to treat staple line leaks after sleeve gastrectomy (SG) but no clear consensus has emerged concerning a management algorithm. OBJECTIVES: Aiming to establish a pattern to tailor treatment, the Spanish Society of Obesity Surgery (SECO) and the Obesity Section of the Spanish Association of Surgeons (AEC) set up a national register to record treatment of leaks after SG. SETTING: Multiple hospital centers, Spain. METHODS: Between September 2016 and December 2017, cases were entered into an online database. Results were assessed according to the number and type of therapeutic procedures. RESULTS: One hundred and five patients from 27 centers were diagnosed with postSG leak. The mean age was 44 years, and 77 (73%) were women. Mean body mass index (BMI) was 47 kg/m2. Mortality was 7%. The first treatment was effective in 50% of cases with no significant differences between nonoperative management and surgery. We found no significant correlations between appearance of leak, type of treatment (nonoperative management or surgery), and treatment effectiveness. An endoscopic stent was the first nonoperative option in 30% of cases and second option in 50% of cases, with effectiveness of 61% and 50%, respectively. In patients requiring a third treatment option (n = 25), surgery was more effective than nonoperative treatment (75% versus 8%) and the incidence of complications secondary to endoscopic stent placement was high (71%). CONCLUSION: The choice of postSG leak treatment depends on the patient's clinical condition and the site of the leak. Healing may be slow (>2 months) and may require several interventions using different approaches such as nonoperative treatment, endoscopic stents, or surgery. The effectiveness of endoscopic options decreases and the effectiveness of complex resective or derivative surgery increases with leak duration and the number of treatments required.


Subject(s)
Bariatric Surgery , Laparoscopy , Obesity, Morbid , Adult , Anastomotic Leak/etiology , Anastomotic Leak/surgery , Bariatric Surgery/adverse effects , Female , Gastrectomy/adverse effects , Humans , Male , Obesity, Morbid/surgery , Retrospective Studies , Spain , Treatment Outcome
9.
Cir. Esp. (Ed. impr.) ; 98(7): 373-380, ago.-sept. 2020. graf, tab
Article in Spanish | IBECS | ID: ibc-198662

ABSTRACT

Se ha propuesto la endoprótesis como tratamiento eficaz de la fístula tras gastrectomía vertical, pero existe variabilidad en los resultados publicados. Para evaluar la efectividad de la endoprótesis como tratamiento de la fuga posgastrectomía vertical, La Sociedad Española de Cirugía de la Obesidad (SECO) y la Sección de Obesidad de la Asociación Española de Cirujanos (AEC) propusieron a sus miembros participar en un registro nacional donde incluir a pacientes con fístula posgastrectomía vertical. Analizamos los tratados con endoprótesis. Diecinueve centros han utilizado endoprótesis. Se colocaron 51 endoprótesis en 42 pacientes, 34 M/8 H, edad media: 43,8 años, IMC: 47,6. Efectividad global: 45%, con 35% de complicaciones. El estudio uni- y multivariado no objetivó factores determinantes de la eficacia del tratamiento. Un mayor diámetro del tubo gástrico se relacionó con una mayor incidencia de complicaciones. No hemos encontrado factores implicados en la efectividad de la endoprótesis. Apenas es efectiva una segunda endoprótesis si la primera no lo fue


It has been suggested that endoprostheses are an effective treatment for fistulae after sleeve gastrectomy, but the results published are very variable. To analyze the effectiveness of stents as treatment of leakage after sleeve gastrectomy, the Spanish Society of Obesity Surgery (SECO) and the Obesity Division of the Spanish Association of Surgeons (AEC) set up a National Registry to record treatments of leaks after sleeve gastrectomy. We have analyzed patients with leaks after sleeve gastrectomy and treated with endoprostheses: 19 medical centers reported the use of endoprostheses, where 51 endoprostheses were used in 42 patients (34 women/8 men, mean age: 43.8 years, BMI: 47.6). Global effectiveness was 45%, with a complication rate of 35%. Uni- and multivariate analyses detected no factors influencing the efficacy of treatment. A larger diameter bouggie used to calibrate the stomach was related to a higher incidence of complications. No factors were found related with better stent efficacy. The effectiveness of a second stent was very low when the previous one had not been effective


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Gastrectomy/adverse effects , Laparoscopy/adverse effects , Gastric Fistula/etiology , Gastric Fistula/surgery , Prostheses and Implants , Drug-Eluting Stents , Bariatric Surgery/adverse effects , Obesity, Morbid/surgery , Treatment Outcome , Retrospective Studies
10.
Int J Biol Macromol ; 164: 1256-1266, 2020 Dec 01.
Article in English | MEDLINE | ID: mdl-32721460

ABSTRACT

The pathways of melanization and sclerotization of the cuticle in insects are carried out by the action of laccases on dopamine and related compounds. In this work, the laccase action of Trametes versicolor (TvL) on catecholamines and related compounds has been kinetically characterized. Among them, dopamine, l-dopa, l-epinephrine, l-norepinephrine, dl-isoprenaline, l-isoprenaline, dl-α-methyldopa, l-α-methyldopa and l-dopa methylester. A chronometric method has been used, which is based on measuring the lag period necessary to consume a small amount of ascorbic acid, added to the reaction medium. The use of TvL has allowed docking studies of these molecules to be carried out at the active site of this enzyme. The hydrogen bridge interaction between the hydroxyl oxygen at C-4 with His-458, and with the acid group of Asp-206, would make it possible to transfer the electron to the T1 Cu-(II) copper centre of the enzyme. Furthermore, Phe-265 would facilitate the adaptation of the substrate to the enzyme through Π-Π interactions. To kinetically characterize these compounds, we need to take into consideration that, excluding l-dopa, l-α-methyldopa and dl-α-methyldopa, all compounds are in hydrochloride form. Because of this, first we need to kinetically characterize the inhibition by chloride and, after that, calculate the kinetic parameters KM and VmaxS. From the kinetic data obtained, it appears that the best substrate is dopamine. The presence of an isopropyl group bound to nitrogen (isoprenaline) makes it especially difficult to catalyse. The formation of the ester (l-dopa methyl ester) practically does not affect catalysis. The addition of a methyl group (α-methyl dopa) increases the rate but decreases the affinity for catalysis. l-Epinephrine and l-norepinephrine have an affinity similar to isoprenaline, but faster catalysis, probably due to the greater nucleophilic power of their phenolic hydroxyl.


Subject(s)
Catecholamines/chemistry , Dopamine/chemistry , Laccase/chemistry , Oxygen/chemistry , Animals , Carbon Isotopes , Catalysis , Catalytic Domain , Computer Simulation , Hydrogen-Ion Concentration , Hydroxyl Radical , Insecta , Kinetics , Magnetic Resonance Spectroscopy , Molecular Docking Simulation , Nonlinear Dynamics , Phenols/chemistry , Polyporaceae/chemistry
11.
Cir Esp (Engl Ed) ; 98(7): 373-380, 2020.
Article in English, Spanish | MEDLINE | ID: mdl-32600648

ABSTRACT

It has been suggested that endoprostheses are an effective treatment for fistulae after sleeve gastrectomy, but the results published are very variable. To analyze the effectiveness of stents as treatment of leakage after sleeve gastrectomy, the Spanish Society of Obesity Surgery (SECO) and the Obesity Division of the Spanish Association of Surgeons (AEC) set up a National Registry to record treatments of leaks after sleeve gastrectomy. We have analyzed patients with leaks after sleeve gastrectomy and treated with endoprostheses: 19 medical centers reported the use of endoprostheses, where 51 endoprostheses were used in 42 patients (34 women/8 men, mean age: 43.8 years, BMI: 47.6). Global effectiveness was 45%, with a complication rate of 35%. Uni- and multivariate analyses detected no factors influencing the efficacy of treatment. A larger diameter bouggie used to calibrate the stomach was related to a higher incidence of complications. No factors were found related with better stent efficacy. The effectiveness of a second stent was very low when the previous one had not been effective.


Subject(s)
Anastomotic Leak/surgery , Gastrectomy/adverse effects , Laparoscopy/methods , Adult , Bariatric Surgery/adverse effects , Female , Fistula/etiology , Fistula/surgery , Humans , Male , Middle Aged , Obesity, Morbid/surgery , Prostheses and Implants/adverse effects , Registries , Stents/adverse effects , Treatment Outcome
12.
Sci Rep ; 10(1): 3974, 2020 03 04.
Article in English | MEDLINE | ID: mdl-32132553

ABSTRACT

Disseminated disease is present in ≈50% of colorectal cancer patients upon diagnosis, being responsible for most of cancer deaths. Addition of biological drugs, as Bevacizumab, to chemotherapy, has increased progression free survival and overall survival of metastatic colorectal cancer (mCRC) patients. However, these benefits have been only reported in a small proportion of patients. To date, there are not biomarkers that could explain the heterogeneity of this disease and would help in treatment selection. Recent findings demonstrated that microRNAs (miRNAs) play an important role in cancer and they can be encapsulated with high stability into extracellular vesicles (EVs) that are released in biological fluids. EVs can act as cell-to-cell communicators, transferring genetic information, such as miRNAs. In this context, we aimed to investigate serum EV associated miRNAs (EV-miRNAs) as novel non-invasive biomarkers for the diagnosis and prognosis of Bevacizumab-treated mCRC patients. We observed that baseline miRNA-21 and 92a outperformed carcinoembryonic antigen levels in the diagnosis of our 44 mCRC patients, compared to 17 healthy volunteers. In addition, patients who died presented higher levels of miRNA-92a and 222 at 24 weeks. However, in the multivariate Cox analysis, higher levels of miRNA-222 at 24 weeks were associated with lower overall survival. Altogether, these data indicate that EV-miRNAs have a strong potential as liquid biopsy biomarkers for the identification and prognosis of mCRC.


Subject(s)
Biomarkers, Tumor/metabolism , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/pathology , Extracellular Vesicles/genetics , MicroRNAs/metabolism , Colorectal Neoplasms/genetics , Disease-Free Survival , Female , Humans , Male , Middle Aged , Neoplasm Metastasis
13.
Cells ; 8(11)2019 11 03.
Article in English | MEDLINE | ID: mdl-31684193

ABSTRACT

Metastasis is the leading cause of cancer-related deaths and despite measurable progress in the field, underlying mechanisms are still not fully understood. Circulating tumor cells (CTCs) disseminate within the bloodstream, where most of them die due to the attack of the immune system. On the other hand, recent evidence shows active interactions between CTCs and platelets, myeloid cells, macrophages, neutrophils, and other hematopoietic cells that secrete immunosuppressive cytokines, which aid CTCs to evade the immune system and enable metastasis. Platelets, for instance, regulate inflammation, recruit neutrophils, and cause fibrin clots, which may protect CTCs from the attack of Natural Killer cells or macrophages and facilitate extravasation. Recently, a correlation between the commensal microbiota and the inflammatory/immune tone of the organism has been stablished. Thus, the microbiota may affect the development of cancer-promoting conditions. Furthermore, CTCs may suffer phenotypic changes, as those caused by the epithelial-mesenchymal transition, that also contribute to the immune escape and resistance to immunotherapy. In this review, we discuss the findings regarding the collaborative biological events among CTCs, immune cells, and microbiome associated to immune escape and metastatic progression.


Subject(s)
Neoplasms/pathology , Neoplastic Cells, Circulating/pathology , Epithelial-Mesenchymal Transition/physiology , Humans , Immunotherapy/methods , Neoplasm Metastasis/pathology
14.
Cell Chem Biol ; 26(8): 1095-1109.e14, 2019 08 15.
Article in English | MEDLINE | ID: mdl-31155508

ABSTRACT

Retrotransposons are a type of transposable element (TE) that have amplified to astonishing numbers in mammalian genomes, comprising more than a third of the human and mouse genomes. Long interspersed element class 1 (LINE-1 or L1) retrotransposons are abundant and currently active retroelements in the human and mouse genomes. Similarly, long terminal repeat (LTR)-containing retrotransposons are abundant in both genomes, although only active in mice. LTR- and LINE-1-retroelements use different mechanisms for retrotransposition, although both involve the reverse transcription of an intermediate retroelement-derived RNA. Retrotransposon activity continues to effect the germline and somatic genomes, generating interindividual variability over evolution and potentially influencing cancer and brain physiology, respectively. However, relatively little is known about the functional consequences of retrotransposition. In this study, we have synthesized and characterized reverse transcriptase inhibitors specific for mammalian LINE-1 retrotransposons, which might help deciphering the functional impact of retrotransposition in vivo.


Subject(s)
Dideoxynucleosides/pharmacology , Long Interspersed Nucleotide Elements/drug effects , Reverse Transcriptase Inhibitors/pharmacology , Cell Line , Dideoxynucleosides/chemical synthesis , Dideoxynucleosides/chemistry , HEK293 Cells , HeLa Cells , Humans , Molecular Structure , Reverse Transcriptase Inhibitors/chemical synthesis , Reverse Transcriptase Inhibitors/chemistry
15.
Breast Cancer Res ; 21(1): 21, 2019 02 06.
Article in English | MEDLINE | ID: mdl-30728048

ABSTRACT

BACKGROUND: Breast cancer patients under neoadjuvant chemotherapy includes a heterogeneous group of patients who eventually develop distal disease, not detectable by current methods. We propose the use of exosomal miRNAs and circulating tumor cells as diagnostic and predictive biomarkers in these patients. METHODS: Fifty-three breast cancer women initially diagnosed with localized breast cancer under neoadjuvant chemotherapy were prospectively enrolled in this study. However, six of them were later re-evaluated and diagnosed as metastatic breast cancer patients by PET-CT scan. Additionally, eight healthy donors were included. Circulating tumor cells and serum exosomal miRNAs were isolated from blood samples before and at the middle of neoadjuvant therapy and exosomal miRNA levels analyzed by qPCR. RESULTS: Before neoadjuvant therapy, exosomal miRNA-21 and 105 expression levels were higher in metastatic versus non-metastatic patients and healthy donors. Likewise, higher levels of miRNA-222 were observed in basal-like (p = 0.037) and in luminal B versus luminal A (p = 0.0145) tumor subtypes. Exosomal miRNA-222 levels correlated with clinical and pathological variables such as progesterone receptor status (p = 0.017) and Ki67 (p = 0.05). During neoadjuvant treatment, exosomal miRNA-21 expression levels directly correlated with tumor size (p = 0.039) and inversely with Ki67 expression (p = 0.031). Finally, higher levels of exosomal miRNA-21, miRNA-222, and miRNA-155 were significantly associated with the presence of circulating tumor cells. CONCLUSION: Liquid biopsies based on exosomal miRNAs and circulating tumor cells can be a complementary clinical tool for improving breast cancer diagnosis and prognosis.


Subject(s)
Antineoplastic Agents/therapeutic use , Biomarkers, Tumor/blood , Breast Neoplasms/diagnosis , Exosomes/genetics , MicroRNAs/blood , Biomarkers, Tumor/genetics , Biomarkers, Tumor/isolation & purification , Breast/diagnostic imaging , Breast/surgery , Breast Neoplasms/blood , Breast Neoplasms/genetics , Breast Neoplasms/therapy , Exosomes/pathology , Feasibility Studies , Female , Gene Expression Profiling/methods , Humans , Liquid Biopsy/methods , MicroRNAs/genetics , MicroRNAs/isolation & purification , Middle Aged , Neoadjuvant Therapy/methods , Neoplastic Cells, Circulating/pathology , Positron Emission Tomography Computed Tomography , Prognosis , Prospective Studies , Treatment Outcome
16.
J Transl Med ; 16(1): 251, 2018 09 06.
Article in English | MEDLINE | ID: mdl-30189880

ABSTRACT

BACKGROUND: The use of circulating tumor cells (CTCs) as indicators of treatment response in metastatic colorectal cancer (mCRC) needs to be clarified. The objective of this study is to compare the Response Evaluation Criteria in Solid Tumors (RECIST) with the Cytologic Criteria Assessing Response (CyCAR), based on the presence and phenotypic characterization of CTCs, as indicators of FOLFOX-bevacizumab treatment response. METHODS: 77 mCRC blood samples from FOLFOX-bevacizumab treated patients were analyzed to isolate CTCs before and after (12 and 24 weeks) treatment, using an immunomagnetic separation method. VEGFR expression was identified by double immunostaining. RESULTS: We observed a decrease of CTCs (42.8 vs. 18.2%) and VEGFR positivity (69.7% vs. 41.7%) after treatment. According to RECIST, 6.45% of the patients did not show any clinical benefit, whereas 93.55% patients showed a favorable response at 12 weeks. According to CyCAR, 29% had a non-favorable response and 71% patients did not. No significant differences were found between the response assessment by RECIST and CyCAR at 12 or 24 weeks. However, in the multivariate analysis, RECIST at 12 weeks and CyCAR at 24 weeks were independent prognostic factors for OS (HR: 0.1, 95% CI 0.02-0.58 and HR: 0.35, 95% CI 0.12-0.99 respectively). CONCLUSIONS: CyCAR results were comparable to RECIST in evaluating the response in mCRC and can be used as an alternative when the limitation of RECIST requires additional response analysis techniques.


Subject(s)
Colorectal Neoplasms/pathology , Neoplastic Cells, Circulating/pathology , Response Evaluation Criteria in Solid Tumors , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cell Line, Tumor , Colorectal Neoplasms/drug therapy , Female , Fluorouracil/therapeutic use , Follow-Up Studies , Humans , Leucovorin/therapeutic use , Male , Middle Aged , Multivariate Analysis , Neoplasm Metastasis , Organoplatinum Compounds/therapeutic use , Prognosis , Proportional Hazards Models , Receptors, Vascular Endothelial Growth Factor/metabolism , Reference Standards , Treatment Outcome
17.
Int J Biol Macromol ; 119: 548-554, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30063931

ABSTRACT

The kinetic action of tyrosinase on l-tyrosine and l-Dopa as substrates in the presence of cinnamic acid and some of its derivatives has been characterized. Cinnamic acid, 2-hydroxycinnamic, 2,3 and 4-methoxycinnamic acids were seen to be inhibitors of tyrosinase being determined the type of inhibition and inhibition constants of all of them. However, 3-hydroxycinnamic, 4-hydroxycinnamic and 3,4-dihydroxycinnamic acids were seen to be substrates of tyrosinase at the same time. The kinetic constants of the catalysis of these substrates were determined and found to be perfectly correlated with the chemical shifts of the carbon with the phenolic hydroxyl group revealed by NMR. Docking studies of 2-hydroxycinnamic and 3-hydroxycinnamic acids showed that tyrosinase is able to hydroxylate 3-hydroxycinnamic acid but is unable to hydroxylate 2-hydroxycinnamic acid.


Subject(s)
Biocatalysis , Cinnamates/chemistry , Cinnamates/pharmacology , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Monophenol Monooxygenase/antagonists & inhibitors , Monophenol Monooxygenase/metabolism , Agaricales/enzymology , Cinnamates/metabolism , Enzyme Inhibitors/metabolism , Kinetics , Molecular Docking Simulation , Protein Conformation
18.
Rev. argent. cir ; 110(1): 1-12, mar. 2018. ilus
Article in Spanish | LILACS | ID: biblio-897362

ABSTRACT

Los sarcomas de células dendríticas foliculares son neoplasias linfoides extremadamente raras. Afectan primordialmente a ganglios linfáticos con compromiso extranodal ocasional. El diagnóstico defini-tivo requiere inmunohistoquímica. Su comportamiento clínico, el tratamiento, así como su evolución resultan poco conocidos. Presentamos el caso de un paciente al que se le diagnosticó un sarcoma dendrítico folicular con afectación axilar.


Folicular dendritic cell sarcoma is an extremelly rare lymphoid neoplasm. Lymph nodes are predominantly afected, but occasionallu extranodal compromise is seen. Definitive diagnosis requires confirmaton by inmunohistochemistry. The clinical features and management are not well know. We present the case follicular dendritic cell sarcoma with axilary afectaton.

19.
Int J Biol Macromol ; 107(Pt B): 2650-2659, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29080822

ABSTRACT

Different mechanisms for inhibiting tyrosinase can be designed to avoid postharvest quality losses of fruits and vegetables. The action of tyrosinase on caffeic acid and its n-nonyl ester (n-nonyl caffeate) was characterized kinetically in this work. The results lead us to propose that both compounds are suicide substrates of tyrosinase, for which we establish the catalytic and inactivation efficiencies. The ester is more potent as inactivator than the caffeic acid and the number of turnovers made by one molecule of the enzyme before its inactivation (r) is lower for the ester. We proposed that the anti-browning and antibacterial properties may be due to suicide inactivation processes.


Subject(s)
Caffeic Acids/pharmacology , Esters/pharmacology , Monophenol Monooxygenase/metabolism , Caffeic Acids/chemistry , Carbon-13 Magnetic Resonance Spectroscopy , Catalysis , Esters/chemistry , Kinetics , Levodopa/metabolism , Molecular Docking Simulation , Quinones/chemistry , Quinones/pharmacology , Substrate Specificity/drug effects , Tyrosine/metabolism
20.
PLoS One ; 12(11): e0187845, 2017.
Article in English | MEDLINE | ID: mdl-29136639

ABSTRACT

Deoxyarbutin, a potent inhibitor of tyrosinase, could act as substrate of the enzyme. Oxytyrosinase is able to hydroxylate deoxyarbutin and finishes the catalytic cycle by oxidizing the formed o-diphenol to quinone, while the enzyme becomes deoxytyrosinase, which evolves to oxytyrosinase in the presence of oxygen. This compound is the only one described that does not release o-diphenol after the hydroxylation step. Oxytyrosinase hydroxylates the deoxyarbutin in ortho position of the phenolic hydroxyl group by means of an aromatic electrophilic substitution. As the oxygen orbitals and the copper atoms are not coplanar, but in axial/equatorial position, the concerted oxidation/reduction cannot occur and the release of a copper atom to bind again in coplanar position, enabling the oxidation/reduction or release of the o-diphenol from the active site to the medium. In the case of deoxyarbutin, the o-diphenol formed is repulsed by the water due to its hydrophobicity, and so can bind correctly and be oxidized to a quinone before being released. Deoxyarbutin has been characterized with: [Formula: see text] = 1.95 ± 0.06 s-1 and [Formula: see text] = 33 ± 4 µM. Computational simulations of the interaction of ß-arbutin, deoxyarbutin and their o-diphenol products with tyrosinase show how these ligands bind at the copper centre of tyrosinase. The presence of an energy barrier in the release of the o-diphenol product of deoxyarbutin, which is not present in the case of ß-arbutin, together with the differences in polarity and, consequently differences in their interaction with water help understand the differences in the kinetic behaviour of both compounds. Therefore, it is proposed that the release of the o-diphenol product of deoxyarbutin from the active site might be slower than in the case of ß-arbutin, contributing to its oxidation to a quinone before being released from the protein into the water phase.


Subject(s)
Arbutin/analogs & derivatives , Monophenol Monooxygenase/chemistry , Arbutin/chemistry , Binding Sites , Catalysis , Copper/chemistry , Hydrophobic and Hydrophilic Interactions , Hydroxylation , Kinetics , Ligands , Molecular Structure , Oxidation-Reduction
SELECTION OF CITATIONS
SEARCH DETAIL
...